RankAlpha logo
Back to Rankings

BOLT

Bolt BiotherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
BOLT vs peer average
62/100
BOLT vs. peer average (D vs. F)
Grade spread
D 2 · F 6
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

XTLB is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $6.06M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerXTLBXTL Biopharmaceuticals
BOLT
Bolt Biotherapeutics
XTLB
XTL Biopharmaceuticals
Grade
D
F
Momentum
41
13
Value
41
46
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs XTLB

BOLT / XTLB
Grade Position
In line
BOLT vs. peer average (D vs. F)
62/100
Momentum
41
BOLT
Value
41
XTLB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BOLT
1
XTLB
XTL Biopharmaceuticals Ltd ADR
F
20/100
+1
2
CVKD
Cadrenal Therapeutics Inc Common
F
20/100
+1
3
CLGN
CollPlant Biotechnologies Ltd Common
F
20/100
+1
4
GELS
Gelteq Ltd Common
D
40/100
Even
5
BGMS
Bio Green Med Solution Inc Common
F
20/100
+1
XTLB is the first peer returned for this comparison set.